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Several classes of environmental contaminants
interact with endocrine targets and may dis-
rupt sex determination and differentiation
and impair reproductive success (1). The con-
sequences of endocrine disruption include
reduced fertility in mammals, abnormal sex-
ual behavior, deformities and lowered survival
of hatchling birds (2), alteration of population
sex ratios in reptiles with temperature-depen-
dent sex determination (3), and feminiza-
tion/masculinization in ﬁsh, both in the adult
(4) or during sexual differentiation (5).
Levels of circulating hormones constitute
important regulatory signals during develop-
ment and in biological functions. These sig-
nals involve mechanisms of feedback loops
between the central nervous system and
effector organs—namely, the hypothalamus-
pituitary-gonad loop of the reproductive
function. The synthesis of estrogens in the
brain (neuroestrogens) plays a critical role in
the differentiation of sex during develop-
ment (6,7) and in sex-specific reproductive
behavior (8), mediating both organizational
and activational effects of the circulating
hormones.
In this study, we investigated sexual
dimorphism in the distribution of the activity
of aromatase (estrogen synthase) in the brain
of the teleost medaka and its regulation by
sex steroids.
Cytochrome P450 aromatase (aromatase)
catalyzes the committed step of the synthesis
of endogenous estrogens from androgens. In
a cascade of reactions, aromatase uses the
reductive equivalents from nicotinamide ade-
nine dinucleotide (NADPH) to convert
androgen (C19) to estrogen (C18) by
removal of the methyl group (C19) and
aromatization of the steroid A ring (9).
Aromatase is the product of the gene family
CYP19. Studies in mammals, including
humans (9), birds (10), and medaka (11),
support the existence of a single locus of the
gene, although the presence of multiple alle-
les has been reported in pigs (12) and gold-
fish (13). The regulatory complexity of
aromatase expression is achieved by use of
alternative gene promoters that are spliced in
a tissue-speciﬁc manner and hormonally reg-
ulated (14,15). Aromatase is evolutionarily
conserved among the classes of vertebrates
studied (16), and it is found in the brain,
gonads, and other peripheral tissues includ-
ing the placenta and the adipose tissue in
mammals (17). In teleosts, levels of aro-
matase in the brain are 100- to 1,000-fold
higher than in the brain of mammals (18).
The adaptive signiﬁcance of the higher levels
of brain aromatase in the evolution of teleosts
is not understood. Teleosts are the group of
vertebrates with the widest heterogeneity and
plasticity of sexual determination and dif-
ferentiation. Sex reversal of the adult blue-
head wrasse (Thalassoma bifasciatum) in
response to social cues (19) and the differ-
ent male morphs of the plainfin midship-
man (Porichthys notatus) (20) illustrate this
diversity.
The role of brain aromatase has been
widely investigated as a regulator of sex-spe-
ciﬁc behavior in mammals (6,21) and birds
(22) and of reproduction in fish (23). The
brain is sexually dimorphic (24). However,
the regulation and signiﬁcance of brain aro-
matase activity are poorly understood. The
high activity levels of aromatase in the brain
of teleosts suggest an important role in regu-
latory pathways and constitute a potential
target for disruption of the endocrine system
by xenobiotics. The characterization of the
activity of brain aromatase and its regulation
are necessary to understand the mechanisms
of control of reproductive function and to
provide a tool for assessing endocrine disrup-
tion. In previous studies, we reported that
the levels of aromatase activity in the brain
of medaka were significantly higher than
those in the gonads and that activity was
speciﬁcally localized to areas of the brain that
contained the hypothalamus (25).
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In this study we identiﬁed sex-dependent dimorphism of brain aromatase in the teleost medaka
and examined its regulation by sex steriods. We ﬁrst investigated differential distribution of brain
aromatase activity in sexually mature male and female medaka in serial coronal sections of the
brain and identified the hypothalamic nuclei contained in each section using the brain atlas of
medaka. In the brain of male medaka, high levels of activity are localized in sections containing
the preoptic (POA) and suprachiasmatic nuclei (SC) (63–75 fmol/hr) and low levels in the nuclei
periventricular dorsalis (HD), ventralis (HV), and caudalis (Hc), nuclei diffusus of lobulus inferi-
ores (NDIL), and nuclei tuberi anteriores (TA) and posteriores (TP) (< 25 fmol/hr). In the brain
of female medaka high aromatase activity is localized in sections containing the HD, HV, Hc,
NDIL, TA, and TP (85–80 fmol/hr) and highly variable levels in the POA and SC (23–70
fmol/hr). The concentration and time dependency of the exposure of male medaka to estradiol on
the total brain aromatase activity and morphologic sex characteristics were determined next.
Estradiol increased the activity of brain aromatase in a concentration-dependent manner at 2.5
and 25 µg/L, but the increase was lower at higher concentrations of the hormone. The effect was
time dependent, gradually increasing up to the fifth day of exposure, after which it reached a
plateau. Estradiol induction of brain aromatase analyzed using Lineweaver-Burke plots of satura-
tion assays revealed a non-ﬁrst-order reaction. The results indicate that a positive feedback mech-
anism regulates brain aromatase and imply that the sexual dimorphic distribution of aromatase
may be highly sensitive to physiologic cues and environmental perturbations in ﬁsh. Key words:
aromatase activity, endocrine disruption, medaka, sexual dimorphism. Environ Health Perspect
109:257–264 (2001). [Online 1 March 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/109p257-264melo/abstract.htmlIn the present study, we characterized
the sexual dimorphism of brain aromatase in
medaka and its regulation by sex steroids.
Our goal was to investigate sexual dimor-
phism in the activity of brain aromatase and
to characterize the effect of exogenous sex
steroids on that activity and on the reversal
of sex phenotype. The organism used was
the drR strain of the medaka (Oryzias
latipes). Medaka are widely used in environ-
mental toxicological assays and were the ﬁrst
teleost in which sex reversal was obtained by
exposure to sex steroids (26,27). We provide
evidence that exposure to exogenous estra-
diol leads to a feminization of the localiza-
tion of aromatase activity of male medaka.
That modification included an increased
activity in speciﬁc areas of the brain that are
usually higher in the female than in the
male. The effect of estradiol on the brain
aromatase activity is both concentration- and
time-dependent. Exposure to the aromatiz-
able androgen methyltestosterone inhibited
the activity of the enzyme to levels not mea-
surable by our methods. This decrease
occurred in all the areas of the brain that had
been shown to have aromatase activity. 
Materials and Methods
Test organism. Cultures of the drR strain of
Japanese medaka (O. latipes) were main-
tained in our laboratory in a balanced salt
solution (27) at 25°C and a 16 hr light:8 hr
dark cycle. Under these conditions animals
breed throughout the year, starting as young
as 2.5 months of age. Sexually mature indi-
viduals (> 5 months) with a body length
25–30 mm were used in our experiments.
Localization of brain aromatase activity.
We used serial sections in the transverse
(coronal) plane of the brain to localize areas
with higher levels of aromatase activity. To
identify sexual dimorphism, we obtained
coronal sections from three individuals of
each nontreated male and female fish. To
study the effects of sex steroids, we obtained
sections from males treated with 250 µg/L
estradiol or 250 µg/L methyltestosterone.
Males treated with DMSO (vehicle) were
used as experimental controls. The experi-
ment was performed with three animals per
treatment. Individuals were quickly anes-
thetized in ice water and decapitated. The
whole head was immediately frozen (–10°C)
and mounted in a cryostat. Coronal sections
of 200 µm, obtained in sequence from the
most anterior area of the brain to the most
posterior, were homogenized in 100 µL of
phosphate buffer (in mM: 10.0 K2PO4,
100.0 KCl, 1.0 EDTA, 1.0 dithiothreitol at
pH 7.4) and stored at –80°C. We measured
aromatase activity in each section, using the
tritiated water aromatase assay method
described below. Levels of aromatase activity
in coronal sections from DMSO-treated
male reproduced those obtained from non-
treated medaka [two-factor analysis of vari-
ance (ANOVA), F0.05(1),1,68 = 2.15, p = 0.14,
F0.05(1),16,68 = 38.8, p = 7 × 10–12,
F0.05(1),16,68 = 1.63, p = 0.08, respectively]. A
medaka brain atlas (28) was used to identify
which hypothalamic nuclei were present in a
given coronal section by correspondence
with morphologic features using a dissecting
microscope.
Aromatase assay. We quantified aro-
matase activity using an in vitro assay, follow-
ing the tritiated water method adapted from
Thompson and Siiteri (29) as described by
Melo et al. (25). Briefly, the stereospecific
release of tritiated water during the conver-
sion of the tritiated substrate 3H-androst-4-
ene-3,17-dione (3H-A) to estrone is used as
an indicator of aromatase activity. Brain
homogenates were incubated for 3 hr at
25°C with 3.0 nM 3H-A in the presence of
1.0 mM NADPH in a phosphate buffer
(described above), in 200 µL total volume of
reaction. The reaction was terminated by
immersion in ice water and addition of 100
µL of 30% trichloroacetic acid (TCA). The
solution was then incubated in a mix of 5%
active charcoal (Norit A; Sigma, St. Louis,
MO) with 0.5% dextrose (Fisher Scientiﬁc,
Pittsburgh, PA) in double-distilled water, for
steroid stripping for 30 min at 4°C. The
mixture was then centrifuged twice at 4°C
and supernatants collected. Levels of tritiated
water produced were determined using 200
µL of the final supernatant by liquid
scintillation counting (1211 RackBeta,
Gaithersburg, MD).
To localize the activity of aromatase in
the brain, we used the tritiated water assay to
measure the enzyme activity separately in the
homogenate of each serial section of the
coronal plane of the brain. To determine the
concentration- and time-dependency of the
effect of sex steroids on the activity of the
enzyme, we used whole-brain homogenates
from individuals exposed in the in vivo
bioassay as a source of enzyme in the triti-
ated water method. We investigated the
kinetics of brain aromatase by performing
saturation aromatase assays using different
concentrations of 3H-A (0.25, 0.35, 0.5, 1.5,
2.5, 4.0, and 5.5 nM). Whole-brain
homogenates of male medaka exposed in
vivo to 2.5 and 25 µg/L estradiol were used
and aromatase activity was compared to con-
trol animals. We analyzed the results graphi-
cally using the double-reciprocal plot
(Lineweaver-Burke plot).
In vivo bioassay. We evaluated the effect
of sex steroids on the activity of aromatase
by exposing 5–7-month-old male medaka to
an estrogen and an androgen. The estrogen
1,3,5 [10]-estratriene-3,17β -diol (E2)
(Sigma), commonly designated estradiol,
and the androgen 17α -methyl-4-androsten-
17β -ol-3-one (MT) (Sigma), designated
methyltestosterone, were dissolved in stock
solutions in DMSO (Sigma). Stock solution
(100 µL) was diluted in 200 mL of aquar-
ium water to obtain the required concentra-
tions of sex steroids in the test vessels, each
holding one animal. Control animals were
exposed to the equivalent volume of the vehi-
cle (DMSO) obtaining a dilution factor of
1:1,000. Exposure lasted for 10 days (except
in the time-dependency experiment,
described below), with water changed every
24 hr. Animals were fed twice a day,
alternating brine shrimp or flake food
(VividColor, Hayward, CA). At the end of
the bioassay, animals were quickly anes-
thetized in ice water and decapitated. For
aromatase activity localization, animals (three
replicates) were exposed to 250 µg/L of estra-
diol or methyltestosterone. At the end of the
assay, the head was frozen and coronal sec-
tions were obtained as described. For the
concentration- and time-dependent evalua-
tion, we dissected whole brains with the aid
of a dissection microscope and homogenized
them in 300 µL of phosphate buffer; ﬁve ani-
mals per treatment were used. We evaluated
the concentration dependency of the effect of
estradiol on brain aromatase activity over
three log concentrations of 2.5, 25, 75, and
250 µg/L of the sex steroid, and ﬁve animals
per treatment were used. We investigated the
time dependency using 20 µg/L of estradiol
and five animals per time point. Animals
were killed after 1, 3, 5, and 10 days of expo-
sure. Control individuals were killed at the
longest (10 days) sampling time. The expo-
sure concentrations used in this study were
pharmacological concentrations 1,000 times
greater than those found in surface waters.
To identify changes in the secondary sexual
characteristics, we photographed each animal
at both times, just before the start of the
exposure assay and after decapitation at the
end of the assay (see description below).
Effects of sex steroids on sex phenotype.
To identify the effects of estrogens and andro-
gens on the sex phenotype, we determined
localization of brain aromatase activity in
coronal sections as described above. We then
compared the aromatase activity to alterations
of secondary sexual characteristics. These
characteristics included the genital papilla, the
presence of papillary processes on the anal ﬁn,
and the notch on the dorsal ﬁn (26,27). The
urogenital papilla is enlarged in females and
small in males. Both the presence of papillary
processes at the posterior region of the anal
ﬁn and a notch in the dorsal ﬁn between the
last and second last fin rays occur only in
males. Enlargement of the urogenital papilla
and a decrease in the notch size and in the
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considered reversal of the secondary sexual
characteristics in medaka. These characteris-
tics were photographed (FlashPoint FPG
3.10; FlashPoint, North Reading, MA)
before and after the in vivo bioassay using a
dissection microscope (Leica MZ12, magni-
ﬁcation 30× ; Leica, Deerﬁeld, IL).
Statistical analysis. Analysis of the exper-
iments using coronal sections of the brain
required a factorial ANOVA to assess simul-
taneously the localization of aromatase activ-
ity in the sequence of brain sections and the
effect of sex or of estradiol treatment. We
used a two-way ANOVA with equal replica-
tion in which the sex or the estradiol treat-
ment (in the respective experiments)
constituted one factor and the localization of
aromatase activity to the coronal brain sec-
tions obtained in sequence constituted the
second factor of the analysis. Considering
the increased probability of obtaining a sta-
tistical type I error due to the large difference
of number of levels in each of the factors (2
in the sex and estradiol treatment and 17 in
the factor of the sections sequence), a two-
way ANOVA using only a subsample of the
sections was also performed. The subsample
of sections selected corresponded to an area
of the brain of interest in this study. The
results of the analysis performed with the
complete set of data and with the subsample
were equivalent. To analyze the data of brain
sections from the experiment of exposure of
males to sex steroids, we used the two-way
ANOVA as follows: First, all the data of sec-
tions from control, estradiol, and methyl-
testosterone treated animals were used. Then
we performed the analysis to compare the
control to the estradiol-treated animals.
Finally, as we did to compare male-to-female
brain aromatase activity, we selected a subset
of sections from the control and estradiol-
treated animals and performed the same
analysis. We analyzed the data from the con-
centration- and time-dependent experiments
using the one-way ANOVA. The groups
contributing to the signiﬁcance of the analy-
sis were identiﬁed by the application of the
multiple-comparison Tukey-Kramer test. To
compare the results from the enzyme satura-
tion assays, we linearized the data in
Lineweaver-Burke double-reciprocal plots,
and applied the linear analysis of regression.
The effect of estradiol on the morphology of
secondary sex characteristics was deﬁned cat-
egorically as an all-or-none type of effect.
The results are presented as the percentage of
animals in each treatment that showed the
phenotypic change.
Results
We examined sexual dimorphism of brain
aromatase by measuring aromatase activity
in serial coronal frozen sections in male and
female fish. The two-factorial ANOVA
showed that the activity of aromatase is sig-
nificantly different between males and
females, and it also is different between sec-
tions of different areas of the brain, showing
an interaction between the effect of these
two factors (F0.05(1),1,68 = 10.91, p = 0.001;
F0.05(1),16,68 = 10.4, p = 1.17 x 10–12; and
F0.05(1),16,68 = 4.15, p = 1.74 x 10–5, respec-
tively). Considering the inequality of the
number of levels between the two factors [17
levels (sections) for the localization factor
and 2 levels (male and female) for the other
factor], we used a subsample of brain sec-
tions (sections 4, 5, 9, 10, and 11), corre-
sponding to areas of the brain that contain
hypothalamic nuclei of interest in this study,
in a two-factor  ANOVA. 
The results of this analysis showed that
the activity of brain aromatase in these sec-
tions is signiﬁcantly different between males
and females and detected a contribution of
the localization to that difference (F0.05(1),1,20
= 10.52, p = 0.004; F0.05(1),4,20 = 2.37, p =
0.08; and F0.05(1),4,20 = 11.26, p = 5.98 ×
10–5, respectively). Brain aromatase was
highest in sections 4–6 of male and in sec-
tions 6–11 of female. One-way ANOVA
performed on individual sections showed
that the activity of brain aromatase in section
4 was signiﬁcantly higher in the male (mean
± SE, 63 ± 9.4 fmol/hr) than in the female
(24 ± 4.4 fmol/hr; F0.05(1),1,4 = 14.09, p =
0.019; Figure 1). In sections 9 and 10 brain
aromatase activity was signiﬁcantly higher in
the female (80 ± 10.5 and 54.6 ± 16.3
fmol/hr, respectively) than in the male (6.1 ±
1.2 and 2.8 ± 0.3 fmol/hr; F0.05(1),1,4 =
48.34, p = 0.002; F0.05(1),1,4 = 48.3, p =
0.002, respectively for sections 9 and 10).
These sections correspond to an area of the
brain that contains specific hypothalamic
nuclei: the preoptic nuclei (POA) and
suprachiasmatic nucleus (SC) in sections 4
through 7, and the nuclei periventricularis
dorsalis (HD), ventralis (HV), caudalis (Hc),
nucleus lateralis (LH), tuberis anteriores
(TA), and tuberis posteriores (TP) in sec-
tions 8 through 11 (Figure 2).
These results reveal sexual dimorphism
in the localization of brain aromatase activity
and suggest the involvement of specific
hypothalamic nuclei, which are contained in
those sections, in the regulation of male or
female functions. When male medaka were
exposed to 250 µg/L estradiol, the localiza-
tion of higher levels of aromatase activity was
statistically different. The application of the
two-factorial ANOVA showed that at the
level of conﬁdence of 5% (α = 0.05), the dif-
ference between the treatments did not
depend on the localization of the activity in
the brain sections (F0.05(1),1,68 = 41.9, p =
1.24 × 10–8; F0.05(1),16,68 = 18.15, p = 1.55 ×
10–18; F0.05(1),16,68 = 1.53, p = 0.113, respec-
tively, for estradiol treatment, sections, and
interaction). To address the possible occur-
rence of a type I error due to the inequality
of levels in each factor (2 for hormone
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Figure 1. Aromatase activity in coronal sections of the brain of male and female medaka. Aromatase
activity is described in femtomoles of tritiated estradione (3H-A) converted to estrone per hour of incuba-
tion, as indicated by the quantification of the tritiated water released in the reaction. Homogenates of
brain coronal 200 µm sections were incubated in a phosphate buffer with tritiated androstenedione and in
the presence of NADPH, for 3 hr at 25°C. Each bar represents the mean ± SE of each section from three
individuals. Asterisks represent a signiﬁcant difference between male and female in the corresponding
brain section. Sections are in sequence (1–17), from the rostral to the caudal side of the brain.treatment and 17 for brain sections), we
applied another two-factorial ANOVA to a
subsample of sections (sections 3, 4, 5, 9,
and 10) that correspond to regions of the
brain of interest in this study. The results of
analysis of the subsample agreed with those
obtained using the entire set of data
(F0.05(1),1,20 = 16.45, p = 0.0006, F0.05(1),4,20
= 4.72, p = 0.0076; F0.05(1),4,20 = 0.82, p =
0.5, respectively, for hormone treatment,
sections, and interaction). The activity of
aromatase was increased in sections 8–11 rel-
ative to the control (Figure 3) with a statisti-
cally signiﬁcant increase in section 9 (12.7 ±
4.3, and 55.0 ± 12.3 fmol/hr in control and
estradiol treated ﬁsh, respectively, F0.05(1),1,4
= 10.4, p = 0.03) suggesting a feminization
of the brain due to the higher levels of estra-
diol. Exposure to methyltestosterone inhib-
ited the activity of aromatase in all the brain
sections of male medaka to levels near the
lower limit of sensitivity of our assay (Figure
4) (F0.05(1),2,102 = 85.29, p = 1.69 × 10–22;
F0.05(1),16,102 = 19.9, p = 1.85 × 10–24;
F0.05(1),32,102 = 4.2, p = 1.6 × 10–8, respec-
tively for hormone treatment, sections, and
interaction).
To determine the concentration-depen-
dent effects of estradiol on the activity of
brain aromatase and on the reversal of the
secondary sex characteristics, we used log
dilutions of 250 µg/L of estradiol (E2) to per-
form in vivo assays with male adult medaka.
Brain aromatase activity was significantly
increased (ANOVA, F0.05(1),4,23 = 10.65, p =
0.0001; Tukey-Kramer, q0.05,20,5 = 2.297, p
< 0.05) following treatments with 2.5 and 25
µg/L E2 when compared to controls (Figure
5). However, the higher concentrations
tested (75 and 250 µg/L), were not statisti-
cally different from those of controls. In par-
allel with the study of the effect of estradiol
on brain aromatase, the reversal of the mor-
phologic secondary sex characteristics of the
treated animals was next investigated with
the aid of a dissection microscope. Of three
separate sex-dependent markers—the genital
papilla, the papillary processes, and the dorsal
ﬁn notch—only the genital papillae exhibited
the female phenotype. The reversal of the sex
phenotype of the genital papilla to female
was observed in 100% of the males in all the
concentrations of estradiol that were tested
and 0% in the control animals (Figure 5).
The time dependency of the effect of
estradiol on the activity of brain aromatase
and on the reversal of the secondary sex
characteristics was investigated next. In vivo
bioassays were performed using 20 µg/L of
estradiol. Time points were 1, 3, 5, and 10
days. The activity of brain aromatase in ﬁsh
exposed to 20 µg/L estradiol increased pro-
gressively with time up to day 5, after which
a plateau was observed (Figure 6). The
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Figure 2. Schematic representation of the brain of medaka, adapted from Anken and Bourrat (28) and modi-
ﬁed using Photoshop 5.0 (Adobe, Mountain View, CA). Abbreviations: Dm3, area medialis of dorsalis telen-
cephali; Hc, hypothalamus periventricularis caudalis; HD, hypothalamus dorsalis; HV, hypothalamus
ventralis; LH, nucleus lateralis hypothalamicus; NDIL, nucleus diffusus of lobus inferiores of hypothalamus;
OT, optic tectus; PMm, nucleus preopticus magnocellularis pars magnocellularis; PPp, nucleus preopticus
parvocellularis posterioris; rin/v3, recessus infundibularis of ventriculus tertius; SC, suprachiasmatic
nucleus; vm, ventriculus mesencephali; VOT, tractus opticus ventralis. An outline of a midsagittal section of
the brain of medaka is shown at the top. Highlighted in yellow and blue are hypothalamic nucleus, and the
overlying lines approximately localize sections 6 (red line) and 9 (blue line) where higher levels of aromatase
activity were found, respectively, in the male and in the female. Connected by arrows are the coronal sec-
tions corresponding to the area localized by the lines overlying the mid-sagittal outline. For clarity, the right
half of the coronal sections outline the structures identiﬁed in that area. 
Dm3
PMm
PPp
SC
VOT
100 µ m
100 µ m
OT
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Hc Hv
rin/v3
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HD
Figure 3. Effect of estradiol on the brain aromatase activity phenotype of male medaka showing aromatase
activity in coronal brain sections of estradiol-treated male ﬁsh compared to that in control ﬁsh (treated
with the vehicle DMSO). Aromatase activity is expressed in femtomoles of converted tritiated estradione to
estrone, as indicated by the measurement of tritiated water released in the reaction. Individuals were
treated with 250 µg/L estradiol for 10 days, sacriﬁced, and coronal 200-µm sections of the brain obtained
and homogenized. Brain section homogenates were incubated in a phosphate buffer, in the presence of 1
mM NADPH, for 3 hr at 25°C. Sections 1–17 are in sequence from the rostral to the caudal side of the brain.
Bars are the mean ± SE of sections from three individuals. Asterisks represent significant difference
(ANOVA, n = 6, p < 0.05) between the two experimental groups, in the indicated brain section.
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)increase in aromatase activity was not signiﬁ-
cantly different from that of controls at day
1, but it was significantly different at all
other time points (3, 5, and 10 days), with
aromatase activity signiﬁcantly higher on day
5 relative to day 3 (ANOVA, F0.05(1),4,24 =
19.44, p = 1.15 × 10–6; Tukey-Kramer,
q0.05,20,5 = 2.297, p < 0.05). Of the three
sexually dimorphic characteristics observed,
only the genital papilla was affected by estra-
diol in a time-dependent manner in our
assays. There was no change in morphologic
sex phenotype after 1 day of exposure to
each of the test concentrations. In the fish
exposed for 3 days, there was a reversal to
female phenotype in 40% of the animals in
the assay with 20 µg/L estradiol. At days 5
and 10 there was 100% reversal to female
phenotype of the genital papillae (Figure 6).
The papillary processes were affected tran-
siently (20% change on day 3, but no
change in samples of day 5 and day 10).
There was no observable effect of estradiol
on the dorsal ﬁn notch in these experiments.
In the experiments testing a range of concen-
trations of estradiol, the genital papilla was
affected in 100% of the animals at every
concentration tested.
To investigate the enzyme kinetics of
brain aromatase in estrogen-treated medaka,
we performed Lineweaver-Burke analysis of
enzyme saturation assays. Saturation curves
obtained with brain homogenates of control
fish and fish exposed to 2.5 and 25 µg/L
estradiol in an in vivo assay were compared.
First-order Michaelis-Menten (Km) type of
curve was observed with the homogenates of
control ﬁsh, with an apparent Km of 1.0 nM
(Figure 7). The saturation curves obtained
with the brain homogenates from estradiol-
treated fish failed to reach a plateau. An
apparent Km of about 5nM, different from
that obtained with the control fish, was
extrapolated. This indicates that the enzyme
is not following a ﬁrst-order type of kinetics.
The effect of estradiol implies the activity of
mechanisms other than a simple increase of
enzyme concentration.
Discussion
We identified sexual dimorphism in brain
aromatase activity of medaka. The male phe-
notype of brain aromatase activity is charac-
terized by the presence of high levels of
activity confined to the coronal sections of
the brain that contain the POA and the SC.
Low levels of activity existed in all the other
brain areas, including those containing the
HD, HV, and Hc. The female phenotype is
characterized by the presence of high aro-
matase activity in coronal sections of the
brain that contain the periventricular nuclei
HD, HV, and Hc, the NDIL, and the TA
and TP. Aromatase activity in sections 6 and
7 of the female is highly variable (range 23
to 70 fmol/hr).
The organizational structure of the
hypothalamus of teleosts comprises func-
tional nuclei as discrete structures distributed
along the longitudinal axis of the brain, in a
medial–ventral localization. An experimental
advantage of this organization is the ability
to analyze groups of nuclei by sectioning the
brain along the longitudinal axis. Using this
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Figure 4. Effect of methyltestosterone on the brain aromatase activity of male medaka. Aromatase activity
is expressed in femtomoles of converted tritiated estradione to estrone, as indicated by the measurement
of tritiated water released in the reaction. Sexually mature male medaka were treated with 250 µg/L
methyltestosterone for 10 days and then were killed. Brains were immediately sectioned, homogenized,
and stored at –80°C until use in aromatase assay. Sections 1–17 are in sequence from the fore- to the
hindbrain. Each bar is the mean ± SE of each section from three individuals. 
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Figure 5. Concentration-dependent effect of estradiol on the activity of brain aromatase and effect on the
sexual phenotype of the genital papillae. The results corresponding to these two independent variables—
brain aromatase activity and morphologic changes in the secondary sexually dimorphic characteristics—
were obtained in the same experiment and from the same animals. Aromatase activity is expressed in
femtomoles of converted tritiated estradione to estrone, as indicated by the measurement of tritiated
water released in the reaction. Male medaka were treated for 10 days with 2.5, 25, 75, or 250 µg/L of estra-
diol and killed, and homogenates of the dissected whole brain were obtained. Each bar is the mean ± SE
of the activity of brain aromatase of five individuals of each treament. The genital papillae were pho-
tographed in a dissecting microscope (magniﬁed 30× ) before and after treatment with estradiol. Control
animals were treated with DMSO, in volume equivalent to that used to dilute the steroid (< 1/1,000). 
*Tukey-Kramer q0.05,20,5 = 2.297, p < 0.05.
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eapproach and making the correspondence
between the brain sections obtained in
sequence from the foremost region of the
brain to those of an atlas of the medaka
brain (28), we identiﬁed those hypothalamic
nuclei contained in the sections where aro-
matase activity in males differed from that in
females. In our previous work, a three-
dimensional representation of brain aro-
matase activity localized the highest activity
levels to a medial ventral area of the brain,
the area that contains the hypothalamic
structures (25). In the work presented here,
we found that in the male, high aromatase
activity occurs in a region of the brain that
contains the preoptic hypothalamic nuclei
and the suprachiasmatic nucleus (sections
4–7, with the highest levels of activity in sec-
tion 6). All the remaining sections of the
male brain (1–3 and 9–17) showed an activ-
ity of aromatase < 25 fmol/hr. In the longi-
tudinal profile of aromatase of the female
brain, higher levels of activity were found in
sections 6–11. Only sections 1–4 and 12–17
(compare to 1–3 and 9–17 in the male) have
aromatase activity < 25 fmol/hr. High vari-
ability among female individuals was found
in sections 6 and 7, but sections 8, 9, 10, and
11 consistently had signiﬁcantly higher levels
than in the males. Sections 8–11 contain the
HD, HV, Hc, LH, TA, TP, and NDIL.
Our results demonstrate sexual dimorphism
of the activity of aromatase in the sections
that contain these nuclei. They are localized
to an area of the brain dorsal to the pituitary,
which appears to correspond to the median
eminence in mammals, an area important in
the release of regulatory factors to the pitu-
itary. The sexual dimorphism of aromatase
activity in this area of the brain of medaka is
probably involved in the sex-speciﬁc regula-
tion of the gonadal–pituitary–hypothalamic
feedback loop. Of consideration is the low
aromatase activity in the gonads of medaka
(25) compared to that in the brain. This sug-
gests that while the regulatory levels of circu-
lating estrogens in mammals depend mostly
on the ovarian synthesis of estrogens in
response to neuroendocrine cues, in teleosts
those levels depend strongly on local synthesis
of estrogens in speciﬁc areas of the brain. 
The high variability between individual
females in the dorsal preoptic area might be
related to a cyclic regulatory control of ovu-
lation or to different ovulatory stages. In
mammals (30) and quail (31), a sexually
dimorphic nucleus (SDN) has been localized
to the corresponding preoptic area. The
presence of aromatase in these nuclei sug-
gests that the local synthesis of estrogens
plays a role in controlling the release of
gonadotropin-releasing/inhibiting factors by
the parvocellular neurons. Another possible
source of local variability of aromatase activ-
ity may be the anterior pituitary. Aromatase
activity in the anterior pituitary was reported
in a teleost species, the longhorn sculpin
(Myoxocephalus octodecimspinosus) (18). Our
data suggest that the aromatase activity in
the preoptic nuclei of medaka is sexually
dimorphic. A study of the aromatase activity
in the pituitary would reveal whether these
nuclei are characterized by consistently lower
levels of aromatase activity in females relative
to males, similar to those observed in the
rostral region of the POA, or by the
observed variability. These fluctuations of
aromatase activity may be related to the
reproductive cycle of the females.
We demonstrated that estradiol adminis-
tered to adult males via the salt solution
alters the anterior–posterior proﬁle of brain
aromatase activity in the neuroaxis to resem-
ble that of the female phenotype. Treatment
of males with estradiol produced a shift of
the sections with high aromatase activity lev-
els, from those containing the POA to those
more caudal areas of the brain. Speciﬁcally,
estradiol increased the levels of aromatase
activity in sections 8–11. Aromatase activity
in these brain sections was sexually dimor-
phic, with low activity levels in the male and
higher levels in the female. The induction of
brain aromatase activity by estradiol has
been shown in medaka (25), goldfish (23),
rats (32), and quail (33). Sexual dimorphism
in total levels of enzymatic activity has been
shown in goldﬁsh (23). In teleosts, the effect
of estradiol to elevate aromatase activity
occurs in a region of the brain corresponding
to the medial basal hypothalamus. The
mechanisms underlying the regulatory path-
ways that give origin to speciﬁc effects in dis-
tinct brain nuclei are not well understood.
Direct (via the estrogen receptor) and/or
indirect (neurotransmitters and other fac-
tors) mechanisms may be involved.
Brain aromatase was inhibited by an
aromatizable androgen in all areas of the
brain where activity was identified. Studies
of the effect of androgens on brain aro-
matase have not led to consistent conclu-
sions. In the ringdove (34), rat (35), quail
(31), and goldfish (23), the aromatizable
androgens induce brain aromatase activity.
Reports have also indicated inhibition in cul-
tures of neural tissue (36) in whole-brain
homogenates of medaka (25) and showed no
effect in certain prenatal stages in rat (24).
These inconsistent results of androgen regu-
lation of brain aromatase activity clearly
demonstrate the interplay of diverging
mechanisms by which androgens affect the
activity of brain aromatase. 
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Figure 6. Time dependency of the effect of estradiol on the activity of brain aromatase and on the sexual
phenotype of the genital papillae. The results corresponding to these two independent variables—brain
aromatase activity and morphologic changes in the secondary sexual characteristics—were obtained in
the same experiment and from the same animals. Aromatase activity is expressed in femtomoles of triti-
ated estradione converted to estrone, as indicated by the measurement of tritiated water released in the
reaction. Male medaka were treated with 20 µg/L estradiol for 1, 3, 5, or 10 days and killed, and whole-
brain homogenates were used in the aromatase assay. Each bar is the mean ± SE of brain aromatase
activity of five individuals in each treatment. The genital papillae were photographed in a dissecting
microscope (magniﬁed 30× ) before and after the treatment with estradiol. Control animals were treated
with DMSO, in volume equivalent to that used to dilute the steroid (< 1/1000).
*Tukey-Kramer q0.05,20,5 = 2.297, p < 0.05. 
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Brain aromatase activityEstrogen exposure has two actions on
brain aromatase in male medaka: elevated
total levels of aromatase activity and local-
ized expression in the medial hypothalamic
nuclei. The total levels of brain aromatase
activity increased with 2.5 and 25 µg/L
estradiol; yet at higher doses (75 and 250
µg/L), signiﬁcant increases were not found.
Alternative regulatory pathways of brain aro-
matase are probably triggered by levels of
estrogens above a certain threshold, which
was achieved in our experiment with the
exposure to 75 µg/L of exogenous estradiol.
Induction of aromatase in the medial hypo-
thalamus was observed at 250 µg/L, a con-
centration where a total brain aromatase
level increase was not observed. Whether this
medial distribution of brain aromatase
occurs at lower doses of estradiol has not yet
been determined. 
The sexual phenotype of the genital
papilla was reversed to the female morph in
males exposed to estradiol. The reversal of
this phenotype was independent of the con-
centrations of estradiol used in our experi-
ments but was dependent on the time of
exposure, following the same pattern of
change of brain aromatase and reaching
100% of sex phenotype reversal after 5 days
of exposure. The effect of estradiol on the
genital papilla seems to be a direct effect of
estradiol on that tissue, leading to cellular
and physiologic processes that increase the
volume of that tissue, probably via estrogen
receptor. The presence of estrogen receptors
in tissues of accessory organs (placenta,
mammary glands) and other tissues (adipose,
bone) is well known in mammals but has
not been investigated in teleosts.
The increase of aromatase activity by
estradiol implies a positive feedback in which
the enzymatic activity is upregulated by the
reaction product. This positive feedback has
been suggested (37), although the mecha-
nisms are still not well understood. Enzyme
induction is a common biological mecha-
nism to increase total enzymatic activity. We
investigated the enzyme kinetics of aro-
matase by performing Lineweaver-Burke
plots to analyze saturation assays. We deter-
mined that the brain aromatase of medaka
has an apparent Km of 1 nM. The apparent
Km of brain aromatase of males treated with
estradiol showed a different value (5 nM).
We conclude that the induction of genetic
expression of aromatase is not the only
mechanism regulating the activity of brain
aromatase. Neurotransmitters such as
dopamine may also modulate the neurosyn-
thesis of estrogens by aromatase. It has also
been suggested that dopamine may interact
directly with aromatase (38). The catechol
metabolites of estrogen can compete with
dopamine for degradation by catechol-O-
methyl transferase, increasing the concentra-
tion of dopamine. Cell volume increase and
the increase of the number of cells can also
increase the activity of aromatase in the
brain.
In summary, we identiﬁed sexual dimor-
phism of brain aromatase activity in medaka.
Estradiol alters the activity of brain aro-
matase in adult male medaka by inducing an
anterior–posterior proﬁle of aromatase activ-
ity distribution in the medial hypothalamus
characteristic of the female. A positive regu-
lation of estradiol on the rate-limiting
enzyme for its synthesis comprises a positive
feedback loop. This positive feedback of
estradiol on the activity of aromatase is a
mechanism that can lead to very high levels
of estrogens in response to a small stimulus
and is a potential target that will lead to
endocrine disruption in the presence of small
alterations of estrogen levels.
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